ID26861A - Terapi gabungan untuk pengobatan depresi refaktori - Google Patents

Terapi gabungan untuk pengobatan depresi refaktori

Info

Publication number
ID26861A
ID26861A IDW20002339A ID20002339A ID26861A ID 26861 A ID26861 A ID 26861A ID W20002339 A IDW20002339 A ID W20002339A ID 20002339 A ID20002339 A ID 20002339A ID 26861 A ID26861 A ID 26861A
Authority
ID
Indonesia
Prior art keywords
refactors
join
depression
therapy
treatment
Prior art date
Application number
IDW20002339A
Other languages
English (en)
Indonesian (id)
Inventor
Gary Dennis Tollefson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ID26861A publication Critical patent/ID26861A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compositions Of Oxide Ceramics (AREA)
IDW20002339A 1998-05-22 1999-05-21 Terapi gabungan untuk pengobatan depresi refaktori ID26861A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8644498P 1998-05-22 1998-05-22

Publications (1)

Publication Number Publication Date
ID26861A true ID26861A (id) 2001-02-15

Family

ID=22198612

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20002339A ID26861A (id) 1998-05-22 1999-05-21 Terapi gabungan untuk pengobatan depresi refaktori

Country Status (24)

Country Link
EP (1) EP0958824A3 (ja)
JP (1) JP2002516282A (ja)
KR (1) KR20010043730A (ja)
CN (1) CN1154496C (ja)
AU (1) AU761510B2 (ja)
BR (1) BR9911049A (ja)
CA (1) CA2332814C (ja)
CZ (1) CZ20004279A3 (ja)
EA (1) EA004539B1 (ja)
HK (1) HK1040055B (ja)
HR (1) HRP20000797A2 (ja)
HU (1) HUP0101901A3 (ja)
ID (1) ID26861A (ja)
IL (1) IL139592A (ja)
MY (1) MY127938A (ja)
NO (1) NO20005885L (ja)
NZ (1) NZ507980A (ja)
PL (1) PL344331A1 (ja)
SK (1) SK17512000A3 (ja)
TR (1) TR200003443T2 (ja)
TW (1) TWI226829B (ja)
UA (1) UA78181C2 (ja)
WO (1) WO1999061027A1 (ja)
ZA (1) ZA200006815B (ja)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU757874B2 (en) * 1998-11-23 2003-03-06 Sepracor, Inc. 2-hydroxymethylolanzapine compositions and methods
EP1396267A3 (en) * 1999-12-06 2004-04-21 H. Lundbeck A/S The combination of a serotonin reuptake inhibitor and a 5-HT2C antagonist, inverse agonist or partial agonist
UA77650C2 (en) * 1999-12-06 2007-01-15 Lundbeck & Co As H Use of serotonin reuptake inhibitor in combination with deramcyclane
EP1353675A2 (en) * 2001-01-02 2003-10-22 PHARMACIA & UPJOHN COMPANY New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents
AU2003268026A1 (en) 2002-07-30 2004-02-16 Peter Migaly Combination therapy for depression, prevention of suicide, and varous medical and psychiatric conditions
EP1723957A3 (en) 2002-12-27 2013-01-23 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders
AR042806A1 (es) 2002-12-27 2005-07-06 Otsuka Pharma Co Ltd Combinacion de derivados de carboestirilo e inhibidores de la reabsorcion de serotonina para el tratamiento de trastornos del animo
FR2851163B1 (fr) * 2003-02-14 2007-04-27 Utilisation de l'enantiomere dextrogyre du milnacipran pour la preparation d'un medicament
CA2537747A1 (en) * 2003-09-04 2005-03-17 H. Lundbeck A/S The combination of a serotonin reuptake inhibitor and loxapine
SG146683A1 (en) 2003-09-17 2008-10-30 Janssen Pharmaceutica Nv Fused heterocyclic compounds as serotonin receptor modulators
EP1713486A4 (en) 2003-12-02 2009-04-29 Sheldon Leslie James COMBINED THERAPY FOR THE TREATMENT OF DEMENTIA, DEPRESSION AND APATHY
WO2005056056A2 (en) * 2003-12-15 2005-06-23 H. Lundbeck A/S The combination of a serotonin reuptake inhibitor and a histamine 3 receptor antagonist, inverse agonist or partial agonist
US7598255B2 (en) * 2005-08-04 2009-10-06 Janssen Pharmaceutica Nv Pyrimidine compounds as serotonin receptor modulators
AU2006282896A1 (en) * 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
BR122020011899B1 (pt) 2006-06-16 2021-05-11 H. Lundbeck A/S processos para a preparação de 1-[2-(2,4-dimetil-fenilsulfanil)-fenil]-piperazina e para a fabricação do sal de adição de ácido bromídrico correspondente
NZ599031A (en) * 2007-02-09 2013-11-29 Alphapharm Pty Ltd A dosage form containing two or more active pharmaceutical ingredients in different physical forms
TWI432194B (zh) * 2007-03-20 2014-04-01 Lundbeck & Co As H ４-〔２-（４-甲基苯硫基）苯基〕哌啶之新穎治療用途
CA2891122C (en) 2012-11-14 2021-07-20 The Johns Hopkins University Methods and compositions for treating schizophrenia
CN105769875A (zh) * 2014-12-22 2016-07-20 扬子江药业集团上海海尼药业有限公司 复方奥氮平盐酸氟西汀胶囊的制备方法
CN108938645A (zh) * 2018-08-24 2018-12-07 山西医科大学第医院 一种抗精神病药物组合物
CN111084778B (zh) * 2019-12-31 2022-06-24 北京鑫开元医药科技有限公司 一种奥氮平盐酸氟西汀胶囊及其制备方法
CN114569566A (zh) * 2020-12-02 2022-06-03 四川科瑞德制药股份有限公司 一种盐酸米那普仑制剂的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992000103A1 (en) * 1990-06-28 1992-01-09 Beecham Group Plc Pharmaceutical preparations
FR2716680B1 (fr) * 1994-02-25 1996-04-05 Adir Nouveaux dérivés de benzodioxane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
NZ326031A (en) * 1996-03-11 2001-05-25 Lilly Co Eli Use of olanzapine in the manufacture of a medicament for treating bipolar disorder
IL126203A (en) * 1996-03-25 2002-12-01 Lilly Co Eli A synergistic painkiller that contains olenzapine and another painkiller
ZA977967B (en) * 1996-09-23 1999-03-04 Lilly Co Eli Combination therapy for treatment of psychoses

Also Published As

Publication number Publication date
IL139592A (en) 2005-08-31
HRP20000797A2 (en) 2001-10-31
CA2332814C (en) 2008-11-04
HK1040055B (zh) 2005-04-01
AU4008699A (en) 1999-12-13
IL139592A0 (en) 2002-02-10
MY127938A (en) 2007-01-31
CN1154496C (zh) 2004-06-23
NO20005885L (no) 2001-01-17
KR20010043730A (ko) 2001-05-25
SK17512000A3 (sk) 2002-02-05
CN1311681A (zh) 2001-09-05
NZ507980A (en) 2003-10-31
JP2002516282A (ja) 2002-06-04
NO20005885D0 (no) 2000-11-21
PL344331A1 (en) 2001-11-05
TR200003443T2 (tr) 2001-03-21
EP0958824A3 (en) 1999-12-01
EP0958824A2 (en) 1999-11-24
CA2332814A1 (en) 1999-12-02
HUP0101901A3 (en) 2002-06-28
EA200001218A1 (ru) 2001-06-25
TWI226829B (en) 2005-01-21
CZ20004279A3 (cs) 2001-09-12
BR9911049A (pt) 2001-02-06
HK1040055A1 (en) 2002-05-24
ZA200006815B (en) 2002-01-14
AU761510B2 (en) 2003-06-05
EA004539B1 (ru) 2004-06-24
HUP0101901A2 (hu) 2001-11-28
WO1999061027A1 (en) 1999-12-02
UA78181C2 (en) 2007-03-15

Similar Documents

Publication Publication Date Title
ID26861A (id) Terapi gabungan untuk pengobatan depresi refaktori
ID24118A (id) Terapi gabungan
ID22878A (id) Komposisi aktif secara terapi
ID25921A (id) Sulfonamida-sulfonamida untuk pengobatan penyakit-penyakit yang dimediakan endotelin
FI20000863A (fi) Uusi hoitomenetelmä
ID27191A (id) Metode untuk pengobatan insomnia
NO20005884D0 (no) Kombinasjonsterapi for behandling av bipolare forstyrrelser
AU3891299A (en) Combination therapy for treatment of depression
ID24275A (id) Terapi kombinasi
ID18679A (id) Penggunaan terapi lanjutan
NO995251D0 (no) FremgangsmÕte for administrering av haloterapi
NO20005179D0 (no) Medikament behandling
ID27483A (id) Metoda terapi gen
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
ID29966A (id) Sulfoniloksazolamina-sulfoniloksazolamina sebagai senyawa-senyawa aktif terapi
ID23528A (id) Pengobatan terapeutik untuk gangguan kulit
NO20014812D0 (no) Fremgangsmåte for tilveiebringelse av kosmetisk/medisinsk terapi
ID24922A (id) Terapi kombinasi untuk pengobatan aids
NO20006383L (no) Fremgangsmåte for behandling
ID29414A (id) Pengobatan depresi
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
NO20012301D0 (no) Ny fremgangsmåte for behandling
ID24521A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
ID17459A (id) Unsur-unsur pengobatan
UA25504A (uk) Спосіб лікуваhhя дисбактеріозу hосоглотки